Edition:
United Kingdom

Cytosorbents Corp (CTSO.OQ)

CTSO.OQ on NASDAQ Stock Exchange Capital Market

9.90USD
16 Nov 2018
Change (% chg)

$0.32 (+3.34%)
Prev Close
$9.58
Open
$9.50
Day's High
$9.93
Day's Low
$9.49
Volume
69,934
Avg. Vol
50,053
52-wk High
$14.90
52-wk Low
$5.80

Chart for

About

CytoSorbents Corporation is a critical care focused immunotherapy company. The Company is engaged in commercializing its product, CytoSorb, which is a blood purification technology with focus in preventing or treating multiple organ failure. The Company's purification technologies are based on biocompatible, porous polymer beads... (more)

Overall

Beta: -0.59
Market Cap(Mil.): $173.02
Shares Outstanding(Mil.): 28.13
Dividend: --
Yield (%): --

Financials

  CTSO.OQ Industry Sector
P/E (TTM): -- 195.28 33.59
EPS (TTM): -0.37 -- --
ROI: -77.87 9.64 15.05
ROE: -162.40 15.60 16.62

Earnings vs. Estimates